Skip to main content

Cancer Immunology, Immunotherapy

Ausgabe 2/2024

Inhalt (20 Artikel)

Cytokine-induced killer (CIK) cells, successes and challenges: report on the first international conference dedicated to the clinical translation of this unique adoptive cell immunotherapy

  • Open Access
  • Meeting Report

Amit Sharma, Xiubao Ren, Antonio Rosato, Dario Sangiolo, Zibing Wang, Sarah Tettamanti, Yi Zhang, Eva Rettinger, Kevin Aaron Fenix, Roberta Sommaggio, Elisa Cappuzzello, Ingo G. H. Schmidt-Wolf

An analysis pipeline for understanding 6-thioguanine effects on a mouse tumour genome

  • Open Access
  • Research

Patricio Yankilevich, Loulieta Nazerai, Shona Caroline Willis, Kjeld Schmiegelow, Daniela De Zio, Morten Nielsen

Butyricimonas is a key gut microbiome component for predicting postoperative recurrence of esophageal cancer

  • Open Access
  • Research

Koji Otsuka, Junya Isobe, Yoshiyuki Asai, Tomohisa Nakano, Kouya Hattori, Tomotake Ariyoshi, Takeshi Yamashita, Kentaro Motegi, Akira Saito, Masahiro Kohmoto, Masahiro Hosonuma, Atsuo Kuramasu, Yuta Baba, Masakazu Murayama, Yoichiro Narikawa, Hitoshi Toyoda, Eiji Funayama, Kohei Tajima, Midori Shida, Yuya Hirasawa, Toshiaki Tsurui, Hirotsugu Ariizumi, Tomoyuki Ishiguro, Risako Suzuki, Ryotaro Ohkuma, Yutaro Kubota, Takehiko Sambe, Mayumi Tsuji, Satoshi Wada, Yuji Kiuchi, Shinichi Kobayashi, Atsushi Horiike, Satoru Goto, Masahiko Murakami, Yun-Gi Kim, Takuya Tsunoda, Kiyoshi Yoshimura

Characterization of T cell receptor repertoire in penile cancer

  • Open Access
  • Research

Junying Zhang, Yapeng Wang, Yiqiang Huang, Xintao Tan, Jing Xu, Qian Yan, Jiao Tan, Yao Zhang, Jun Zhang, Qiang Ma, Hailin Zhu, Jin Ye, Zhaojing Zhu, Weihua Lan

Novel mechanism of drug resistance triggered by tumor-associated macrophages through Heat Shock Factor-1 activation

  • Open Access
  • Research

Alina D. Nikotina, Snezhana A. Vladimirova, Nadezhda E. Kokoreva, Valeria A. Nevdakha, Vladimir F. Lazarev, Liubov S. Kuznetcova, Elena Y. Komarova, Roman V. Suezov, Sergei Efremov, Elizaveta Leonova, Viktor G. Kartsev, Nikolay D. Aksenov, Boris A. Margulis, Irina V. Guzhova

Personalized neoantigen vaccine enhances the therapeutic efficacy of bevacizumab and anti-PD-1 antibody in advanced non-small cell lung cancer

  • Open Access
  • Research

Xiuhua Lin, Shichuan Tang, Yutong Guo, Ruijing Tang, Zhenli Li, Xinting Pan, Geng Chen, Liman Qiu, Xiuqing Dong, Ling Zhang, Xiaolong Liu, Zhixiong Cai, Baosong Xie

Unexpected chronic lymphocytic leukemia B cell activation by bisphosphonates

  • Open Access
  • Research

Andrea N. Mazzarello, Elena Gugiatti, Vanessa Cossu, Nadia Bertola, Davide Bagnara, Sonia Carta, Silvia Ravera, Chiara Salvetti, Adalberto Ibatici, Fabio Ghiotto, Monica Colombo, Giovanna Cutrona, Cecilia Marini, Gianmario Sambuceti, Franco Fais, Silvia Bruno

Tumor characteristics of dissociated response to immune checkpoint inhibition in advanced melanoma

  • Open Access
  • Research

J. M. Versluis, E. P. Hoefsmit, H. Shehwana, P. Dimitriadis, J. Sanders, A. Broeks, C. U. Blank

Presence of Epstein–Barr virus (EBV) antigens detected by sensitive methods has no influence on local immune environment in diffuse large B cell lymphoma

  • Open Access
  • Research

T. Mangiaterra, R. Alonso-Alonso, A. Rabinovich, M. De Dios Soler, L. Galluzzo, M. Soria, S. Colli, E. De Matteo, S. M. Rodriguez Pinilla, P. Chabay

New CEACAM-targeting 2A3 single-domain antibody-based chimeric antigen receptor T-cells produce anticancer effects in vitro and in vivo

  • Open Access
  • Research

Iga Jancewicz, Magdalena Śmiech, Magdalena Winiarska, Radoslaw Zagozdzon, Pawel Wisniewski

Targeting CD24/Siglec-10 signal pathway for cancer immunotherapy: recent advances and future directions

  • Open Access
  • Review

Xingchen Li, Wenzhi Tian, Zhongxing Jiang, Yongping Song, Xiangyang Leng, Jifeng Yu

The complex role of IL-10 in malignant ascites: a review

  • Open Access
  • Review

Yue Huang, Kangni Zou, Heng Jiang, Zhengyu Li

A CAR-T response prediction model for r/r B-NHL patients based on a T cell subset nomogram

  • Open Access
  • Research

Xiaomei Zhang, Rui Sun, Meng Zhang, Yifan Zhao, Xinping Cao, Ruiting Guo, Yi Zhang, Xingzhong Liu, Cuicui Lyu, Mingfeng Zhao

Activation of cytotoxic lymphocytes through CD6 enhances killing of cancer cells

  • Open Access
  • Research

Mikel Gurrea-Rubio, Qi Wu, M. Asif Amin, Pei-Suen Tsou, Phillip L. Campbell, Camila I. Amarista, Yuzo Ikari, William D. Brodie, Megan N. Mattichak, Sei Muraoka, Peggy M. Randon, Matthew E. Lind, Jeffrey H. Ruth, Yang Mao-Draayer, Shengli Ding, Xiling Shen, Laura A. Cooney, Feng Lin, David A. Fox

Unraveling T cell exhaustion in the immune microenvironment of osteosarcoma via single-cell RNA transcriptome

  • Open Access
  • Research

Debin Cheng, Zhao Zhang, Dong Liu, Zhenzhou Mi, Weidong Tao, Jun Fu, Hongbin Fan

CD74 is associated with inflamed tumor immune microenvironment and predicts responsiveness to PD-1/CTLA-4 bispecific antibody in patients with solid tumors

  • Open Access
  • Research

Jianghua Wang, Xiaoting Li, Guanxi Xiao, Jayesh Desai, Sophia Frentzas, Zhongmin Maxwell Wang, Yu Xia, Baiyong Li

A comprehensive pan-cancer analysis of prognostic value and potential clinical implications of FTH1 in cancer immunotherapy

  • Open Access
  • Research

Yuejun Luo, Chengming Liu, Yuxin Yao, Xiaoya Tang, Enzhi Yin, Zhiliang Lu, Nan Sun, Jie He

Updated systematic review and network meta-analysis of first-line treatments for metastatic renal cell carcinoma with extended follow-up data

  • Open Access
  • Review

Takafumi Yanagisawa, Keiichiro Mori, Akihiro Matsukawa, Tatsushi Kawada, Satoshi Katayama, Kensuke Bekku, Ekaterina Laukhtina, Pawel Rajwa, Fahad Quhal, Benjamin Pradere, Wataru Fukuokaya, Kosuke Iwatani, Masaya Murakami, Karim Bensalah, Viktor Grünwald, Manuela Schmidinger, Shahrokh F. Shariat, Takahiro Kimura

Enhanced T cell immune activity mediated by Drp1 promotes the efficacy of PD-1 inhibitors in treating lung cancer

  • Open Access
  • Research

Jietao Ma, Jun Song, Xiaofang Yi, Shuling Zhang, Li Sun, Letian Huang, Chengbo Han

Neu im Fachgebiet Onkologie

Positive Phase IIb-Studie zu mRNA-gestützter CAR-T bei Myasthenia gravis

Eine auf das B-Zell-Reifungsantigen gerichtete mRNA-basierte CAR-T-Zell-Therapie wurde jetzt in einer ersten Phase IIb-Studie zur Behandlung der generalisierten Myasthenia gravis mit Placebo verglichen.

NSCLC: Hirnmetastasen durch elektrische Felder eindämmen

Zur Behandlung von Hirnmetasen bei nicht-kleinzelligem Lungenkrebs (NSCLC) stehen verschiedene Optionen zur Verfügung. TTFields – eine lokoregionäre, nicht-invasive physikalische Therapie – könnte sich hier einreihen.

Kontrollkoloskopie nach Polypektomie: Wann ist eine zweite Untersuchung nötig?

Wann benötigen polypektomierte Patienten und Patientinnen mehr als eine endoskopische Nachsorgeuntersuchung? Eine Kohortenstudie aus Großbritannien legt eine konkrete Strategie nahe.

Wenn die Krebstherapie die Identität verändert

Tumortherapien können die Fingerbeere so verändern, dass eine Fingerabdruck-abhängige Identitätskontrolle fehlschlägt. Dafür sprechen zumindest Daten aus der Literatur, die Forschende nun erstmals für ein Review zusammengetragen haben. Vieles ist im Moment aber noch unklar.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.